Clinical Trials Directory

Trials / Completed

CompletedNCT01283126

Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Joslin Diabetes Center · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to find out the effects of hypoglycemia on cognition in healthy individuals and how well changes in (interstitial) tissue glucose levels correlate with changes in cognitive function as compared to blood glucose levels.

Detailed description

Subjects will undergo hypoglycemic clamps during which interstitial glucose will be measured and cognitive function will be assessed.

Conditions

Interventions

TypeNameDescription
PROCEDUREeuglycemic and hypoglycemic clampSubjects will undergo standard euglycemic and hypoglycemic clamps, and will have concurrent assessments of cognitive function and measurement of interstitial glucose concentrations.

Timeline

Start date
2011-01-01
Primary completion
2014-10-01
Completion
2015-10-01
First posted
2011-01-25
Last updated
2017-05-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01283126. Inclusion in this directory is not an endorsement.

Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery (NCT01283126) · Clinical Trials Directory